2018 and Vaccines - Pharmacy Technician Pulse

Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025

Drug Topics

JUNE 23, 2025

Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.

Community Pharmacies

Community Pharmacies Specialty Pharmacies Compounding Independent Pharmacies

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Drug Topics

JULY 17, 2025

Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.

Specialty Pharmacies

Specialty Pharmacies Mayo Clinic Patient Care Compounding

Self-Care Measures for Preventing and Managing Dysmenorrhea

Pharmacy Times

JUNE 20, 2025

December 2018. link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. American Pharmaceutical Association; 2025. Dysmenorrhea and endometriosis in the adolescent. American College of Obstetricians and Gynecologists. Accessed April 28, 2025. Smith RP, Kaunitz AM. UpToDate.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

JULY 19, 2025

2018 ESC/ESH guidelines for the management of arterial hypertension. 2018; 39: 3021–3104. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 2017.11.006 Williams B, Mancia G, Spiering W, et al. Eur Heart J.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Immunization

Avatrombopag Receives FDA Approval for Treamtent of Pediatric Patients With Chronic Immune Thrompcytopenia

Pharmacy Times

JULY 25, 2025

It was initially approved in 2018 for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure. May 21, 2018. Despite efficacious treatments that lead to remission, many patients relapse after multiple lines of therapy. Avatrombopag (oral route). Mayo Clinic. July 1, 2025. Accessed July 25, 2025.

Immunization

Immunization FDA Mayo Clinic Adverse Reactions

Invest a Few Minutes in Inhaler Counseling

Pharmacy Times

JULY 23, 2025

The global asthma report 2018. August 31, 2018. Every inhaler needs to be inspected periodically to make sure that it’s still clean and in good shape. 14,18 Conclusion It may seem like counseling on inhaler use could take too much time, but with practice, it can take minutes. REFERENCES Global Asthma Network. Accessed June 6, 2025.

Hospitals

Hospitals Compounding Pharmacies Immunization FDA

Fremanezumab-Vfrm Approved by FDA for Preventative Treatment of Episodic Migraine in Children, Adolescents

Pharmacy Times

AUGUST 6, 2025

This indication expands on fremanezumab’s initial FDA approval in 2018. The SPACE trial showed fremanezumab significantly reduced monthly migraine days and acute medication use compared to placebo. The treatment is administered monthly and can be given at home, aiding adherence and reducing treatment burden.

FDA

FDA Compounding Pharmacies Independent Pharmacies Immunization

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

JUNE 20, 2025

December 13, 2018. American Oncology Network. August 8, 2024. Accessed May 15, 2025. How your oncology peers manage the complexities of care. Oncology Live ®. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development. December 12, 2019. Updated January 19, 2024. Accessed May 15, 2025.

Compounding

Compounding Compounding Pharmacies Patient Care Immunization

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

JUNE 10, 2025

August 24, 2018. Additionally, like all NSAIDs, meloxicam injection should be used with caution in patients with cardiovascular, gastrointestinal, or renal risk factors. 2 REFERENCES 1. Schwenk E, Mariano E, et al. Designing the ideal perioperative pain management plan starts with multimodal analgesia. Korean Journal of Anesthesiology.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents FDA Compounding Pharmacies Hospitals

IBI303, Humira Biosimilar, Shows Comparable Efficacy and Cost Benefit to Reference Product

Pharmacy Times

JULY 24, 2025

Updated June 4, 2018. Accessed July 22, 2025. link] Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis. ClinicalTrials.gov identifier: NCT02893254. Accessed July 22, 2025.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmTech

JUNE 23, 2025

Molecules 2018 , 23 (7) 1719. Recent Videos Related Content Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics Cheryl Barton June 24th 2025 Article mRNA technologies offer great promise in immunotherapy and non-immunogenic applications. Drugs.com , last updated March 21, 2025 (accessed April 29, 2025). Sutariya, V.;

Compounding

Compounding Dosage Labelling FDA

Prescribing Cascades Can Often Lead to Polypharmacy for Older Adults

Drug Topics

JULY 30, 2025

Patients were considered incident users, which included use of both medications in each of the 9 Think Cascade dyads from January 1, 2018, to December 31, 2020. Updated COVID-19 mRNA Vaccine Did Not Increase Risk for Adverse Events Ashley Gallagher July 29th 2025 Article The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Specialty Pharmacies Independent Pharmacies Vaccines

Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds

Pharmacy Times

JULY 8, 2025

1,2 The authors wrote that a 2018 survey from the Crohn’s and Colitis Foundation reported that health care professionals expressed discomfort when prescribing biosimilars in the pediatric population compared with adults. One patient started Inflectra in 2016 and 2017. There was a slow uptake of infliximab biosimilar use among the ICN centers.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Hospitals

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Pharmacy Times

JUNE 10, 2025

Thus, the reduced number of newly licensed pharmacists versus PharmD graduates: 2 In 2018, there were 14,905 PharmD graduates and 14,103 taking the NAPLEX for the first time. The number of PharmD graduates will likely dip below 10,000 in the next 5 years (a reduction of 33% from 2018).

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

FDA Approves Ketamine for Surgical Pain Management

Pharmacy Times

AUGUST 11, 2025

3 Since February 2018, ketamine has been regularly listed on the FDA’s drug shortage list, highlighting a significant need for a consistent and high-quality supply. Notably, the FDA did not express concern about the stability of the Ketarx submission batches, nor were new preclinical and clinical studies requested.

FDA

FDA Compounding Pharmacies Compounding Immunization

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

PharmTech

AUGUST 11, 2025

Needle of a syringe protrudes through the rubber cap of a vaccine vial with red cap. 2018 (accessed October 2023). SHOW MORE Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more sustainable product. OECD Environment Directorate. Chemicals and Biotechnology Committee.

Packaging

Packaging Dosage Vaccines FDA

Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder

Drug Topics

JUNE 10, 2025

She admitted she was using them for injection drug use, and I gave her 5 syringes we were using for COVID-19 vaccine injections that were provided by the government. She was most grateful and assured me she was going to seek help the next day.

Health and Personal Care Stores

Health and Personal Care Stores Vaccines Immunization Controlled Substances

Every Claim You Make, Every Step You Take…CVM Will Be Watching You

The FDA Law Blog

APRIL 7, 2025

Zenrelia comes with serious warnings, including a boxed warning against the use of Zenrelia during vaccination. CVM also objected to the truncation of other information about the timing of vaccines in these promotional materials. Zenrelia promotional materials also included claims about clinical data that the Agency found actionable.

Vaccines

Vaccines FDA Adverse Reactions

Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML

Pharmacy Times

AUGUST 7, 2025

2018;(38):555-573. Updated March 28, 2018. Genes (Basel). 2020;11(8):845. doi:10.3390/genes11080845 Kuykendall A, Duployez N, Boissel N, Lancet JE, Welch JS. Acute myeloid leukemia: the good, the bad, and the ugly. Am Soc Clin Oncol Educ Book. doi:10.1200/edbk_199519 Lancet JE, Uy GL, Cortes JE, et al. J Clin Oncol. doi:10.1200/ JCO.2017.77.6112

Chemotherapy

Chemotherapy FDA Hospitals Immunization

Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer

Pharmacy Times

JULY 1, 2025

031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%

Compounding Pharmacies

Compounding Pharmacies Insurance Vaccines Immunization

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

Pharmacy Times

JULY 18, 2025

link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Updated May 6, 2020. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025.

Compounding

Compounding Compounding Pharmacies Documentation FDA

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

PharmTech

JUNE 24, 2025

cancer and vaccines), and non-immunogenic applications (e.g., cancer and vaccines), and non-immunogenic applications (e.g., Several types of mRNA-based vaccines have emerged, namely non-replicating linear mRNAs (NRM), self-amplifying mRNAs (saRNAs), and circular mRNAs (circRNAs). Types of messenger RNA (mRNA)-based vaccines.

Vaccines

Vaccines Dosage FDA Immunization

Shruti Ayyalasomayajula, PharmD

Blog: Ask a Student Pharmacist

JULY 29, 2025

A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population. Vaccines 2023, 11, 623. .; Elnaem, M.H.; Sridhar, S.; Unnikrishnan, M.K. link] Dhawan A, Ayyalasomayajula S, Karattuthodi MS, Manu MK, Hisham M, Shareef J, Sridhar SB.

Vaccines

Wildfires Have Significant Impacts on Respiratory Health

Drug Topics

JUNE 9, 2025

Research from the University of Colorado Boulder found that there were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades, with fire frequency doubling on the East and West coasts and quadrupling in the Great Plains regions. describes airborne particles with a diameter of 2.5

Compounding

Compounding Immunization Vaccines Specialty Pharmacies

Barriers are limiting UK childhood vaccination, say doctors

pharmaphorum

JULY 1, 2025

Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

JULY 11, 2025

How will RFK Jr’s American dream for vaccines play out? The rising volume of clinical trials increases demand and competition for patients The number of oncology assets in the clinical development pipeline has increased by 13% annually over five years (2018-2022) 1. On paper, this sounds like a positive time for medical innovation.

Hospitals

Hospitals FDA Medical Records Packaging

Novartis’ ribociclib approved in Canada for early breast cancer

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In March 2018, Health Canada approved Novartis’ therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer. In March 2018, Health Canada approved the therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer.

Communication

Communication Hospitals Packaging Insurance

GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA Vaccines

Planning, not panic, as BIO weighs in on US vaccination woes

pharmaphorum

JUNE 19, 2025

Skip to main content Thursday 19 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies Insurance

Biopharma's costly blind spot: Exhausted minds, expensive mistakes

pharmaphorum

AUGUST 7, 2025

Skip to main content Thursday 7 August 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA Packaging

Dupilumab Shows Superiority Over Omalizumab for Chronic Rhinosinusitis

Drug Topics

JUNE 16, 2025

[link] Recent Videos Related Content Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.

Specialty Pharmacies

Specialty Pharmacies Compounding Independent Pharmacies Immunization

MSD bolsters US manufacturing capacity with $1b investment

European Pharmaceutical Review

MARCH 12, 2025

MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. This expansion forms part of the company s $12 billion US capital investment since 2018. The intention is to widen its manufacturing and R&D capabilities and boost recruitment in the US.

Research Laboratories

Research Laboratories Vaccines

Danish Study Affirms Safety of Aluminum in Childhood Vaccines

Pharmacy Times

JULY 23, 2025

million children found no link between aluminum exposure from vaccines and chronic diseases. million children found no link between aluminum exposure from vaccines and chronic diseases. The research supports the safety of childhood vaccines, addressing concerns about aluminum-containing adjuvants.

Vaccines

Vaccines Compounding Pharmacies Immunization Specialty Pharmacies

Study: High Long-Term Exposure to Fine Particulate Air Pollution is Associated With Diffuse Myocardial Fibrosis

Pharmacy Times

JULY 7, 2025

Patients with dilated cardiomyopathy (DCM) or controls with normal cardiac MRI findings from January 2018 to December 2022 were included. is associated with diffuse myocardial fibrosis, a precursor to heart failure, as shown by increased native T1 z-scores in cardiac MRI. “We µm or smaller aerodynamic diameter (PM2.5)—which

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

Wockhardt has high hopes for novel antibiotic Zaynich

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA Vaccines

Moderna shines spotlight on new flu vaccine data

pharmaphorum

JUNE 30, 2025

Skip to main content Monday 30 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA

MSD to advance investigational Lp(a) inhibitor in nearly $2b deal

European Pharmaceutical Review

MARCH 25, 2025

MSDs recent $1 billion manufacturing investment In another recent investment, earlier this month, MSD opened a new vaccine manufacturing facility in the US. The new vaccine manufacturing facility utilises innovative capabilities such as data analytics, generative AI, as well as 3D printing.

Research Laboratories

Research Laboratories Vaccines

15th World Clinical Biomarkers & Companion Diagnostics Summit | Free* for Biopharma

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA

UK plans to invest 'billions' in Essex biosecurity centre

pharmaphorum

JULY 18, 2025

Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Vaccines

Merck Ebola vaccine Ervebo shown to offer substantial protection

STAT

AUGUST 21, 2024

Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had been vaccinated at least 10 days before being exposed to the virus, a new study reports. Read the rest…

Vaccines

Moderna plans triple vaccine targeting flu, COVID and RSV

pharmaphorum

JULY 8, 2021

Buoyed by the success of its COVID-19 vaccine, Moderna has started a phase 1/2 trials of its mRNA-based shot for seasonal influenza, targeting four different flu strains. . Ultimately, the goal is to develop a shot that combines seasonal flu, COVID-19 and respiratory syncytial virus (RSV) protection with a single vaccine, said the biotech.

Vaccines

STAT+: Cancer vaccine startup launches with $54 million, Spark veteran as CEO

STAT

APRIL 18, 2024

A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures.

Vaccines

Vaccines Hospitals

Sanofi and Translate take first mRNA flu vaccine into clinic

pharmaphorum

JUNE 22, 2021

Sanofi and Translate Bio have started a first clinical trial of an mRNA-based seasonal flu vaccine, adding to the COVID-19 shot already in testing as part of their three-year old collaboration. Sanofi and Translate have been working together since 2018, when they agreed to develop mRNA vaccines for up to five infectious diseases.

Vaccines

Vaccines Immunization

Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech

Pharmaceutical Technology

NOVEMBER 26, 2024

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Vaccines

Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Trending Sources

Self-Care Measures for Preventing and Managing Dysmenorrhea

Hypertension: A Silent Killer Requiring Novel Therapies

Avatrombopag Receives FDA Approval for Treamtent of Pediatric Patients With Chronic Immune Thrompcytopenia

Invest a Few Minutes in Inhaler Counseling

Fremanezumab-Vfrm Approved by FDA for Preventative Treatment of Episodic Migraine in Children, Adolescents

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

IBI303, Humira Biosimilar, Shows Comparable Efficacy and Cost Benefit to Reference Product

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

Prescribing Cascades Can Often Lead to Polypharmacy for Older Adults

Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

FDA Approves Ketamine for Surgical Pain Management

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder

Every Claim You Make, Every Step You Take…CVM Will Be Watching You

Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML

Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

Shruti Ayyalasomayajula, PharmD

Wildfires Have Significant Impacts on Respiratory Health

Barriers are limiting UK childhood vaccination, say doctors

The unsustainability of clinical trials and need for transformative change

Novartis’ ribociclib approved in Canada for early breast cancer

GRIN Therapeutics: Seeking to address unmet needs in rare neurodevelopmental disorders

Planning, not panic, as BIO weighs in on US vaccination woes

Biopharma's costly blind spot: Exhausted minds, expensive mistakes

Dupilumab Shows Superiority Over Omalizumab for Chronic Rhinosinusitis

MSD bolsters US manufacturing capacity with $1b investment

Danish Study Affirms Safety of Aluminum in Childhood Vaccines

Study: High Long-Term Exposure to Fine Particulate Air Pollution is Associated With Diffuse Myocardial Fibrosis

Wockhardt has high hopes for novel antibiotic Zaynich

Moderna shines spotlight on new flu vaccine data

MSD to advance investigational Lp(a) inhibitor in nearly $2b deal

15th World Clinical Biomarkers & Companion Diagnostics Summit | Free* for Biopharma

UK plans to invest 'billions' in Essex biosecurity centre

Merck Ebola vaccine Ervebo shown to offer substantial protection

Moderna plans triple vaccine targeting flu, COVID and RSV

STAT+: Cancer vaccine startup launches with $54 million, Spark veteran as CEO

Sanofi and Translate take first mRNA flu vaccine into clinic

Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech

Stay Connected